ArticleInternational journal of clinical oncology2015

Hypofractionated chemoradiotherapy with temozolomide as a treatment option for glioblastoma patients with poor prognostic features.

Yu Jin Lim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.